U.S. flag

An official website of the United States government

Medicaid State Plan Amendments

A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.

When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.

Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.

Results

Displaying 8071 - 8080 of 15843

Michigan
This state plan amendment modifies the Graduate Medical Education (GME) Innovations Program to include a sponsoring institution program, Authority Health.
Approval Date: October 17, 2017
Effective Date: January 1, 2017

Iowa
The amendment requires that any Medicaid provider or provider entity that receives payments, in any federal fiscal year, of at least $5,000,000 must have written policies for all employees and contractors, and must educate employees and contractors regarding: 1) The Federal False Claims Act under title 31 of the United States Code, sections 3729 through 3733; 2) Administrative remedies for false claims and statements under title 31 of the United States Code, chapter 38; 3) Any State laws pertaining to civil or criminal penalties for false claims and statements ( Iowa Code chapters 249A and 685 and Iowa Code sections 714.8(10)-714.14); 4) Whistleblower protections under such laws; and 5) the provider or provider entity's policies and procedures for detecting and preventing fraud, waste, and abuse.
Approval Date: October 17, 2017
Effective Date: July 1, 2017
Topics: Financing & Reimbursement Program Administration

Nevada
This amendment, effective September 19,2017, allows a reduction to Medicaid upper payment limit. supplemental payments for non-state governmentally-owned or operated hospitals in order to preserve their disproportionate share hospital adjustment payment levels.
Approval Date: October 17, 2017
Effective Date: September 19, 2017
Topics: Financing & Reimbursement

Virginia
To add text to the State Plan regarding reimbursement practices for community mental health services and to reflect the inclusion of updated dental procedure codes in the agency's fee schedule.
Approval Date: October 17, 2017
Effective Date: October 15, 2017
Topics: Financing & Reimbursement Program Administration

Ohio
Coverage & Limitations and Payment for Services: Other Licensed Practitioners - Non-Physician Licensed Behavioral Health Practitioner Services.
Approval Date: October 17, 2017
Effective Date: July 1, 2017
Topics: Financing & Reimbursement

New Jersey
This amendment will maintain reimbursement rates at their present level for one year.
Approval Date: October 16, 2017
Effective Date: July 1, 2016
Topics: Financing & Reimbursement

Kentucky
This amendment was submitted as a technical correction to update the reimbursement methodology for Laboratory Services.
Approval Date: October 16, 2017
Effective Date: July 1, 2017
Topics: Financing & Reimbursement Program Administration

Massachusetts
To update payment rates for personal care attendant services.
Approval Date: October 16, 2017
Effective Date: July 1, 2017
Topics: Financing & Reimbursement

Maine
Adds Opioid Health Home services as authorized under Section 2703 of the Patient Protection and Affordable Care Act.
Approval Date: October 13, 2017
Effective Date: October 1, 2017
Topics: Health Homes Prescription Drugs

Georgia
This SPA proposes to bring Georgia into compliance with the reimbursement requirements in the Covered Outpatient Drug final rule with comment period (CMS-2345-FC).
Approval Date: October 13, 2017
Effective Date: April 1, 2017